Drugs / CLS2901C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06549686 | Oct 2023 → Dec 2028 expected | osteoarthritis, knee | CellSeed Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLS2901C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06549686 ↗ |
| Modality | Cell therapy | “The investigational human cellular based product is a cell sheet made by culturing and growing chondrocytes taken from cartilage tissue derived from patients with polydactyly.” NCT06549686 ↗ |